Skip to main content
Premium Trial:

Request an Annual Quote

Score One for Open Access

Publishing company Springer has acquired BioMed Central, the largest open access publisher with more than 180 peer-reviewed journals. Springer's Derk Haank said in a statement, "This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade."

Over at Open Access News, Peter Suber's already parsing the news, starting with his reasoning that Springer will maintain the open access status of all the BMC journals. He adds that this deal should not be seen "as a sign of BMC's failing health. On the contrary. ... The purchase is a sign of Springer's confidence that BMC will continue its long, steady climb from the red to the black."

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.